Pfizer and BioNTech, the makers of Comirnata’s COVID-19 vaccine, have applied to the U.S. Food and Drug Administration (FDA) for conditional approval to give it to children 5-11 years of age.
“As the number of new cases in children in the United States remains high, this conclusion is an important step in our continued efforts against COVID-19,” Pfizer wrote on Twitter. The company said it has asked the FDA for conditional approval to use the vaccine for children 5-11 years of age.
“The goal is to protect children from this serious threat,” emphasized the vaccine manufacturer.
So far, the FDA has issued full approval for the Pfizer vaccine for people over the age of 16. For children 12-15 years of age, a conditional authorization from the agency still applies.
Vaccinations against COVID-19 in the United States
In the United States, over 55 percent of people are fully vaccinated. More than 64 percent have already taken at least one dose. The US FDA has approved three vaccines – Moderny, Pfizer / BioNTech and Johnson & Johnson.
Main photo source: PAP / EPA / ETIENNE LAURENT